Completed OBSERVATIONAL NCT01715857

Clinical Practice of Inhalation Anesthesia With Sevoflurane in China

A Multicenter Registry on the Clinical Practice of Inhalation Anesthesia With Sevoflurane in China

Sponsor: AbbVie (prior sponsor, Abbott)

Updated 6 times since 2017 Last updated: Aug 15, 2014 Started: Jul 31, 2012 Primary completion: Jul 31, 2013 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Anesthesia, General, this trial is completed. The trial is conducted by AbbVie (prior sponsor, Abbott) and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AbbVie (prior sponsor, Abbott)

Data source: AbbVie

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beijing, China , Beijing, Xicheng District, China , Changchun, Jilin, China , Changsha, Hunan, China , Chengdu, China , Chongqing, China , Guangzhou, China , Guangzhou, Guangdong, China , Harbin, Heilongjiang, China , Jinan, Shandong, China and 11 more locations